• Telemedicine company based in Miami and led by a Serbian founder Health Index raises $6 million in funding round co-led by LAUNCHub Ventures and Inovo Venture Partners
• Index Health seeks to revolutionize healthcare with personalized and data-driven medicine, and focuses on heart health, women’s health, autoimmunity and gut health.
• The seed round injected by CEE investors into an American-first company proves the growing ambition of the region’s founders and venture capital firms.
Founded in late 2020, the company plans to allocate part of its new capital to recruit high-level medical professionals and talented engineers for product development.
They also aim to expand operations launched in Florida to all 50 US states and continue certified laboratory partnerships in each state.
“Our goal is to have one million members in 3 years, and it’s achievable, there’s no doubt about it. The root cause method proves its superiority over ubiquitous prescription drugs. Our first cohort of tested patients saw an 80% improvement via the root cause method compared to what had previously been tried with chronic disease treatment. Luka Ivicevicsaid the co-founder and CEO of Index Health in a statement.
Chronic frustration with the ineffectiveness of traditional approaches
According to Ivicevic, the idea for Index Health was born primarily out of chronic frustration stemming from the ineffectiveness of traditional approaches to treating conditions such as cardiovascular disease and diabetes.
“Identification of the root cause of the disease, with the involvement of medical professionals and thorough laboratory testing, is largely lacking. Ditto active surveillance. We are hiring more doctors to maintain high medical standards,” Ivicevic said.
SO, Index Health leverages telemedicine, advanced laboratory testing and comprehensive EHR (electronic health records) with a good measure of AI capabilities to accelerate the processing of medical data for personalized diagnoses.
Index Health’s data-driven approach is also nearly three times cheaper than prescription chronic disease treatment, saving $4,000 in annual expenses, the company said.
“This is what ‘technology’ in health technology should be: empowering healthcare professionals to get to the root of the problem instead of applying band-aids and simply relieving the symptoms . We are excited to invest in an experienced team with an excellent track record, ready to evolve and heal,” Todor Breshkov, Managing Partner at LAUNCHHub Businesses, said.
According to Michal Rokosz of Inovo Venture Partners, Index Health has the right solution at the right time.
“Laboratory testing allows us to better understand the root cause of health problems. Combined with technology and patients’ willingness to be treated via telemedicine, this is a product with remarkable market fit. We are confident that a few big companies will be created in this market and Index Health will be one of them. We consider Luka to be one of the most focused and effective founders we have worked with,” Rokosz highlighted.
